Exciting news from last week’s Future4care DemoDay! Sanofi and Biolevate are officially joining forces to revolutionize AI-assisted literature reviews using the Biolevate Knowledge platform! By combining Sanofi’s deep expertise with Biolevate’s cutting-edge tech, dozens of professionals are now going deeper, faster, and smarter into thousands of healthcare papers. Why is this a game-changer? Mathieu Giraud from Sanofi highlighted three key pillars of our success: 1) Unmatched accuracy in scientific knowledge extraction. 2) A flexible platform tailored to insights from Sanofi HEVA experts (shoutout to Hugo Dubucq, Adeline ABBÉ, Paulo CARITA, Divyesh Thakker, DIWAKAR JHA, M.PHARM, M.B.A, Sirish Cholasamudram, Amitkumar Pagada, Bhavik Shah, MPharm (Clinical Pharmacy), PhD and the entire team!) and their support teams Jennifer Gangnard Artemy Gvozdev, PMP®. 3) Massive long-term potential. During a panel with Pius S. Hornstein, MSc, PhD & Joel Krikston, Pius shared some mind-blowing stats: the platform is already handling tens of thousands of extractions per day and millions per week! When Joel Krikston asked "Why Biolevate?", the answer was clear: Scalability. We don’t just serve one department or one country or one use case, we scale across the entire organization. We speak the language of the end-users and focus on solving real enterprise needs, not just the tech for tech's sake. #HealthTech #AI #Innovation #Sanofi #Biolevate #Future4Care #DemoDay #DigitalHealth #Partnership
About us
At Biolevate, we believe that accelerating science means elevating humans. We help life science organizations turn their knowledge into scalable intelligence by connecting data, documents, and expertise across the enterprise. Our AI-native Knowledge Platform standardizes complex scientific workflows by connecting knowledge and reasoning. From unstructured content to structured insight, from isolated experts to organization-wide intelligence, your best practices become your standard. By freeing scientists, engineers, and experts from repetitive or manual work, Biolevate allows teams to focus on what truly matters: discovering, innovating, and advancing faster.
- Website
-
https://biolevate.com
External link for Biolevate
- Industry
- Software Development
- Company size
- 11-50 employees
- Type
- Privately Held
- Founded
- 2024
Employees at Biolevate
Updates
-
Biolevate reposted this
Honoured to share the stage with Mathieu Giraud to announce the result of our collaboration between Sanofi and Biolevate at Future4care's DemoDay. What started as a focused RFP has now become a collaboration with already deployed and used by teams internationally with a clear acceleration on: - literature exploration - scientific evidence recollection - AI adoption with compliance and traceability This is a fantastic start but as mentioned during today’s panel by Pius S. Hornstein, MSc, PhD, solving a real operational challenge is only part of the story; the real impact comes from designing solutions that can scale across an organization by supporting a wide range of use cases. The result we jointly obtained so far will pave the way for many more success toward this goal. A special thank you to Future4care for fostering an ecosystem that makes collaborations like this possible, and to everyone involved on both sides who contributed to this journey.
-
-
Biolevate will be at Future4care European #DemoDay this Thursday in Paris. Meet the team and discover how we're helping life science organizations accelerate their daily works. See you there! joel Belafa Antoine de Torcy Cécile-Aurore Wotawa Florence A. C. Jérôme Cabannes Maxime Gobin, PhD Alexandre Olivier #Future4Care #Biolevate #DemoDay
-
-
Les équipes Biolevate sont très fières d'avoir remporté le challenge Servier de Techinnov "Neuro-inflammation : identification et évaluation de cibles thérapeutiques". Un grand merci aux équipes de Servier et de BioLabs France pour leur confiance ! Cela annonce de très beaux projets à venir. CCI Essonne - Chambre de commerce et d’industrie de région Paris Ile-de-France Celine Triquel - Georges Da violante - Julien Verdier - Franck AUGE - Nadia Benallal #Spartners #Servier #BiolabsFrance #Biolevate #AccelerateHealthcareInnovations #OCEAN
[CHALLENGE SERVIER🏆] Et le grand gagnant est… 🥁 Parmi toutes les candidatures reçues, une #startup a su convaincre par sa vision et la pertinence de sa réponse aux enjeux des #maladies #neurologiques rares. Biolevate et sa plateforme #IA OCEAN remporte le Challenge Servier 2026 à Techinnov ! 🥳 #OCEAN ne fait pas de la bio-informatique classique. Elle ne liste pas des gènes. Elle explique pourquoi. En croisant des données multi-omiques, la plateforme reconstruit la logique causale des maladies pour identifier des cibles thérapeutiques que les approches conventionnelles ne voient pas. Dans le domaine des pathologies neurologiques, c'est une rupture. 🎯 1 brevet déposé · 2 en cours · +5 indications validées · #TRL 6 🏢 6 mois gratuits au sein de l'incubateur #Spartners by Servier France & BioLabs France 🤝 Une mise en relation avec le pôle Search & Evaluation de la R&D Servier France pour explorer des opportunités scientifiques et partenariales Un immense bravo à toute l'équipe Biolevate pour cette reconnaissance méritée 👏 et merci à tous les candidats du Challenge Servier 2026. Le niveau était au rendez-vous. 👉 Swipez pour découvrir OCEAN, la plateforme qui change la façon dont on découvre les médicaments de demain. Prenez RDV avec eux : joel Belafa, Marie Barbier, Jérôme Cabannes, Florence A. C., Maxime Gobin, PhD 👉 https://lnkd.in/eu9Xhbe7 CCI Essonne, Chambre de commerce et d’industrie de région Paris Ile-de-France I Celine Triquel, Georges Da violante, Julien Verdier, Franck AUGE, Nadia Benallal
-
-
-
-
-
+2
-
-
Biolevate reposted this
A 100x faster healthcare ecosystem. Nothing less. We reinvented these technologies to pave the way for a truly accelerated healthcare ecosystem, and this investment is already bearing fruit: • Biolevate is already powering 20+ automated processes across different departments, organizations, and stakeholders. (Pharma CROs CDMOs Hospitals and Regulators ). • We transform complete clinical and regulatory workflows (search, screening, review, and reporting), achieving a 30x to 100x speed increase. By shifting the mental burden of information-heavy tasks to an agentic system, we aren't just improving accuracy, time-to-market, or the economic equation. We are giving teams the space to focus on what matters most: maximising the efficacy and safety of our treatments. And it's only the beginning. We built this tech to drive AI adoption where it's needed most. We are excited to soon share how our knowledge-anchored approach helped us crack some of the most complex bottlenecks in drug discovery pipelines. We have also recently entered talks with major private and public institutions to fight rare and orphan diseases. Their trust, and the treatment candidates this collaboration has already managed to identify, is our greatest motivation. Visit : https://www.biolevate.com/
-
🇫🇷 Fiers d’accompagner AIOLOS 2.0, plateforme nationale France 2030 pour la détection précoce, le suivi en temps réel et la prévision des épidémies de virus respiratoires. Biolevate apporte l’infrastructure cœur data & IA : intégration intelligente de données hétérogènes, structuration en base de connaissance exploitable, et orchestration de workflows d’IA de confiance, traçables et auditables. Cela permet aux autorités de santé de disposer d’alertes et prévisions robustes, fondées sur une intelligence collective fiable. Notre engagement : une surveillance des pathogènes respiratoires souveraine, agile et pérenne - au service de la France et de l’Europe. Les données de santé, comme bien public, au cœur de l’innovation française. 🇬🇧 We are proud to support AIOLOS 2.0, the national France 2030 platform for early detection, real-time monitoring, and forecasting of respiratory virus epidemics. Biolevate provides the core data and artificial intelligence infrastructure: intelligent integration of heterogeneous data sources, structuring into actionable knowledge repositories, and orchestration of trustworthy, traceable, and auditable artificial intelligence workflows. This enables health authorities to access robust alerts and forecasts grounded in reliable collective intelligence. Our commitment: establishing a sovereign, agile, and sustainable respiratory pathogen surveillance system - in service to France and Europe alike. Health data as a public good, at the heart of French innovation. #IA #Santé #France2030 #IDCluster #DonnéesDeSanté #Souveraineténumérique #Biolevate #AIOLOS #AI #Health #HealthData
AIOLOS: France’s real-time epidemic radar 📡 The COVID-19 pandemic has revealed the need for faster, more flexible epidemiological surveillance that is capable of leveraging heterogeneous data. The solution: a national AI-powered platform to better detect, monitor, and manage the response to epidemics and pandemics of respiratory viruses. ➡️ Multi-source data (hospitals, biology, genomics, wastewater, social signals, weather…). ➡️ Predictive analytics to detect outbreaks early. ➡️ Decision dashboard for real-time crisis management. ➡️ Participative citizen app with local risk alerts ("virus weather forecast"). Led by Cédric Mahé with the support of Sanofi and its partners Hospices Civils de Lyon - HCL, Impact Healthcare, and Biolevate, AIOLOS is one of the innovations accelerated by Infectious Diseases Cluster 🇫🇷, where science, industry, and public health unite to turn research into real-world impact. Stay tuned to discover the next projects! --- Christophe JACQUINET Perrine Martin-Jeantet Philippe Leissner François Lacoste Bruno Lina ANRS Maladies infectieuses émergentes AP-HP, Assistance Publique - Hôpitaux de Paris bioMérieux INSTITUT MÉRIEUX CEVA SANTE ANIMALE Hospices Civils de Lyon - HCL Institut Pasteur Lyonbiopôle Auvergne-Rhône-Alpes Sanofi Université Claude Bernard Lyon 1 Université Paris Cité
-
Biolevate reposted this
Biolevate started with a belief that felt impossible: Changing how we discover medicines and how they reach people faster. We kept building through the complexity, the long nights, because this mission doesn’t get a pause button. Now it’s time to share what that persistence has made possible. Over the coming weeks, we’ll be releasing a series of announcements: - new drug discovery results and program milestones in orphan diseases - step-change gains in speed and cost - partnerships that unlock more data across more underserved indications To every patient, caregiver, clinician, and researcher still pushing forward: we see you, and we fight with you. This is just the beginning.
-
-
Biolevate reposted this
Nous vous attendons à STATION F demain pour Les "Grandes Tendances de la E-santé" . C’est dans cet évènement que nous avons rencontré le premier client international de Biolevate. Merci Jérôme LELEU et toute l’équipe.
-
-
Biolevate reposted this
🇬🇧🚨 #Esanté26 [D-1] Let’s meet tomorrow! 📍 Station F, Paris | January 27 👉 Meet the Biolevate team at 𝗕𝗼𝗼𝘁𝗵 𝟮𝟰! Let’s discuss how Biolevate supports the entire #LifeSciences value chain with 𝘁𝗿𝘂𝘀𝘁𝗲𝗱 and 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝘁 AI. 🇫🇷🚨 #Esanté26 [J-1] 📍 Station F, Paris | 27 janvier 👉 Retrouvez Biolevate sur le 𝗦𝘁𝗮𝗻𝗱 𝟮𝟰 Venez échanger autour de vos enjeux et découvrir les cas d'usage couverts par la plateforme Biolevate pour accélérer les #LifeSciences grâce à une IA de 𝗰𝗼𝗻𝗳𝗶𝗮𝗻𝗰𝗲 et 𝗰𝗼𝗻𝗳𝗼𝗿𝗺𝗲.
-